跳至主要内容
临床试验/ACTRN12605000149662
ACTRN12605000149662已完成不适用

A multi-centre randomised controlled trial to evaluate whether early jejunal feeding increases energy delivery in critically ill patients

ICU Rsearch Department, The Alfred Hospital, Melbourne Victoria0 个研究点目标入组 180 人开始时间: 2005年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • ICU patients are eligible for enrolment if they meet all of the following: in ICU for less than 48 hours prior to enrolment, receiving invasive mechanical ventilation (through an endotracheal tube or tracheostomy, NOT a facemask) with an anticipated need for more than 48 hours of mechanical ventilation, receiving a continuous infusion of any one of morphine (>2mg/hour, fentanyl (> 20mcg/hour), or pethidine (>20mg/hour), either a single GRV > 150mls (whilst receiving EN via an NG tube, or nasogastic drainage >500mls over 12 hours (whether receiving EN or not).

排除标准

  • Patients will be ineligible for enrolment if they meet any of the following criteria: previous or recent surgery which has altered the anatomy of the gastrointestinal tract (eg. oesophagectomy, gastrectomy, any gastric anastomosis surgery, gastroplasty, pyloroplasty, pancreaticoduodenectomy (Whipple's procedure), known gastric malignancy, known oesophageal varices, current admission for peptic ulceration, current mechanical bowel obstruction, current gastostomy, jejunostomy, or surgically placed enteral tube in situ, contraindication to the use of the nose and mouth for enteral tube insertion (eg recent facial trauma or surgery), receiving nutritional support prior to ICU admission, severe coagulopathy (defined by platelet count <20 and/or INR>4.0).

研究者

发起方
ICU Rsearch Department, The Alfred Hospital, Melbourne Victoria

相似试验

进行中(未招募)
1 期
Stem cell transplantation versus disease modifying therapy (alemtuzumab or ocrelizumab) for patients with highly active relapsing remitting MSHighly active relapsing remitting multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2019-001549-42-GBSheffield Teaching Hospitals198
招募中
不适用
A multicenter randomized controlled trial to evaluate overall morbidity after total minimally invasive esophagectomy versus hybrid esophagectomyC15.9Oesophagus, unspecified
DRKS00027927Klinik für Allgemeine, Viszeral- und Transplantationschirurgie Universitätsklinikum Tübingen152
已完成
不适用
Efficacy of preemptive inferior mesenteric artery embolization during endovascular aortic aneurysm repairAbdominal aortic aneurysm
JPRN-UMIN000035502ara Medical University142
尚未招募
3 期
A multicenter randomized controlled trial to evaluate the length of hospital stay of intracorporeal versus extracorporeal anastomosis in laparoscopic colectomy for colon cancercolon cancer
JPRN-UMIN000041565Gastroenterological Center, Yokohama City University Medical Center300
进行中(未招募)
3 期
A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna (LM) when staged surgical excision with 5mm margins is not possible, is refused, or fails.entigo maligna (LM)Lentigo maligna (LM)Cancer - Non melanoma skin cancer
ACTRN12615000266561Melanoma and Skin Cancer (MASC) Trials126
The Early Nasojejunal Tube to Meet Energy ... | 临床试验